CBU
MXCT icon

CIBC Bancorp USA’s MaxCyte MXCT Stock Holding History

CIBC Bancorp USA’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$17K Buy
+10,779
New +$18.7K ﹤0.01% 1460

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.05B AUM 22.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
AIM
AXA Investment Managers Puteaux, France $37.1B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIBC Bancorp USA's MXCT Position: Q3 2025 in Review

CIBC Bancorp USA opened a new position in MaxCyte (MXCT) in Q3 2025: 10,779 shares worth $17K. The stake represents ﹤0.01% of the portfolio and ranks #1460 among its holdings.

112 funds tracked by Wall St. Rank hold MXCT as of Q3 2025.

  • CIBC Bancorp USA held 10,779 shares of MaxCyte worth $17K as of Q3 2025.
  • MaxCyte was a new CIBC Bancorp USA position in Q3 2025.
  • MaxCyte made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2025, its #1460 holding.
  • 112 funds tracked by Wall St. Rank held MaxCyte as of Q3 2025.

Based on CIBC Bancorp USA's 13F filing for Q3 2025, filed 12 Nov 2025.